Faruk Kadri BAKKAL, Nagihan GÜLHAN, Fakih Cihat ERAVCI, Yusuf KIZIL, Utku AYDİL

Head and neck lymphomas from otolaryngology perspective

Aim: To evaluate the clinical manifestations, histopathologic composition, and demographic characteristics of the lymphomas presented in the head and neck. Materials and Methods: Records of subjects who had a diagnosis of lymphoma by an otolaryngology clinic in a tertiary referral hospital between May 2007 and July 2017 were reviewed. Demographic features and data regarding histopathology, radiology, and clinical presentation were evaluated. Results: A total of 103 lymphomas in the head and neck region, 79 (77%) nodal lymphoma, and 24 (23%) extranodal lymphoma, were diagnosed. The initial presentation was solitary lymphadenopathy in 12 (15%) of the nodal lymphomas but conglomerated or multiple lymphadenopathies in the others. No significant relationship was found between lymph node size and histopathology (p=0.144). Extranodal lymphomas presented most commonly in tonsils (n=8, 33%). Hodgkin lymphoma to non-Hodgkin lymphoma ratio was 0.8 (35/44) among nodal lymphomas. The dominant subgroup of non-Hodgkin lymphomas was diffuse large b-cell lymphoma (n=18, 40%). All of the Hodgkin lymphomas in our series were classic variant, and the subjects were younger than the non-Hodgkin lymphomas (z=-4.803, p

Keywords:

Lymphoma, head and neck, malignancy,

PDF

___

Cooper JS, Porter K, Mallin K, et al. National Cancer Database report on cancer of the head and neck: 10‐year update. Head Neck 2009; 31: 748-58.
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375-90.
Zapater E, Bagán J, Carbonell F, Basterra J. Malignant lymphoma of the head and neck. Oral Dis 2010; 16: 119-28.
Weber AL, Rahemtullah A, Ferry JA. Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am 2003; 13: 371-92.
Urquhart A, Berg R. Hodgkin's and non‐Hodgkin's lymphoma of the head and neck. Laryngoscope 2001; 111: 1565-9.
Beasley M. Lymphoma of the thyroid and head and neck. Clin Oncol 2012; 24: 345-51.
Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertu P. Extranodal lymphomas of the head and neck: a 20-year experience. Arch Otolaryngol Head Neck Surg 1997; 123: 1318-23.
Oluwasanmi AF, Wood SJ, Baldwin DL, Sipaul F. Malignancy in asymmetrical but otherwise normal palatine tonsils. Ear Nose Throat J 2006; 85: 661-3.
Woo J-S, Kim JM, Lee S, Chae S, Hwang S, Lee HM. Clinical analysis of extranodal non-Hodgkin's lymphoma in the sinonasal tract. Eur ArchOtorhinolaryngol 2004; 261: 197-201.
Ahuja AT, Ying M, Ho SY, et al. Ultrasound of malignant cervical lymph nodes. Cancer Imaging 2008; 8: 48-56.
Burke C, Thomas R, Inglis C, et al. Ultrasound-guided core biopsy in the diagnosis of lymphoma of the head and neck. A 9 year experience. Brit J Radiol 2011; 84: 727-32.
Nyquist GG, Tom WD, Mui S. Automatic core needle biopsy: a diagnostic option for head and neck masses. Arch Otolaryngol Head Neck Surg 2008; 134: 184-9.
Allin D, David S, Jacob A, Mir N, Giles A, Gibbins N. Use of core biopsy in diagnosing cervical lymphadenopathy: a viable alternative to surgical excisional biopsy of lymph nodes? Ann R Coll Surg Eng 2017; 99: 242-4.
Houcine Y, Romdhane E, Blel A, et al. Evaluation of fine needle aspiration cytology in the diagnosis of cervical lymph node lymphomas. J Craniomaxillofac Surg 2018; 46: 1117-20.
Etemad-Moghadam S, Tirgary F, Keshavarz S, Alaeddini M. Head and neck non-Hodgkin's lymphoma: a 20-year demographic study of 381 cases. Int J Oral Max Surg 2010; 39: 869-72.
Roman E, Smith A. Epidemiology of lymphomas. Histopathology 2011; 58: 4-14.
Alexander FE, Ricketts TJ, McKinney PA, Cartwright RA. Community lifestyle characteristics and incidence of Hodgkin's disease in young people. Int J Cancer 1991; 48: 10-4.
Phan A, Veldman R, Lechowicz MJ. T-cell lymphoma epidemiology: the known and unknown. Curr Hematol Malig Rep 2016; 11: 492-503.
Agostinelli C, Pileri S. Pathobiology of hodgkin lymphoma. Mediterr J Hematol I 2014; 6: e2014040.
Glaser SL, Lin RJ, Stewart SL, et al. Epstein‐Barr virus‐associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997; 70: 375-82.
Said JW. Aggressive B-cell lymphomas: how many categories do we need? Mod Pathol 2013; 26: S42-S56.
Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 1995; 85: 1075-82.
Al‐Hamadani M, Habermann TM, Cerhan JR, Macon WR, Maurer MJ, Go RS. Non‐H odgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011. Am J Hematol 2015; 90: 790-5.